Columbia Laboratories, Inc. (CBRX) Posts Mixed Q1 Results

Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q1 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $3.8 million versus the consensus estimate of $5.9 million.

For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
• Marchex (MCHX) Reports In-Line Q2 EPS